Topic: Gilead Sciences Inc.

AP News | 2009-03-12 23:02:40
<div id="subtitle">Gilead Sciences' CEO John Martin's compensation falls 1 percent in 2008</div><div><p>Gilead Sciences Inc. President and Chief Executive John C. Martin's total compensation fell about 1 percent to $12.55 million in 2008 mainly due to fewer stock and option awards, according to a ...
Continue reading... 
7 Funds Betting Big on Health Care

SmartMoney | 2010-02-26 17:41:36

Biotech Glance: Biotechnology companies

Boston Globe | 2010-02-22 13:45:23

The Good and Bad of AIDS Research

Conde Nast Portfolio | 2009-11-24 14:12:18

Are Health Insurers Worth Bashing?

Baseline Scenario | 2010-03-15 13:10:57

loading
loading
loading